Greenland Mines Unit Receives Australian Patent for Gene Therapy Technology
MT Newswires Live
Jul 10
Greenland Mines (GRML) said Friday that its biotech division was granted a patent by IP Australia covering Klotho gene therapy technology for the treatment of neuromuscular diseases.
The patent, entitled "Treatment of Neuromuscular Diseases via Gene Therapy that Expresses Klotho Protein," protects the use of human gene therapy using a muscle-cell specific promoter linked to a nucleic acid gene sequence encoding the human Klotho s-KL protein for treating motor impairment, the company said.
Shares of Greenland Mines were 1.4% higher in premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.